Orviva

Learn · Pharmacogenomics · CYP1A2

Caffeine and CYP1A2

CYP1A2 clears about 95% of caffeine. Fast, inducible metabolisers feel less effect and clear it before bedtime; slow metabolisers keep it in circulation for many hours, and some studies link slow metabolism plus heavy coffee to higher cardiovascular risk.

Stimulant CPIC level B · Source: PharmGKB / PMID:16522833

Why does CYP1A2 matter for Caffeine?

CYP1A2 clears about 95% of caffeine. Fast, inducible metabolisers feel less effect and clear it before bedtime; slow metabolisers keep it in circulation for many hours, and some studies link slow metabolism plus heavy coffee to higher cardiovascular risk. CYP1A2 is the enzyme that clears caffeine, and it also metabolises clozapine, olanzapine, theophylline and melatonin. Unlike most pharmacogenes, its activity is driven at least as much by environment as by genotype: smoking and cruciferous vegetables induce it, oral contraceptives and fluvoxamine inhibit it. The *1F variant makes the enzyme more inducible, which is why the same coffee affects a smoking *1F/*1F carrier and a non-smoking *1A/*1A carrier so differently.

What does CPIC recommend for each CYP1A2 phenotype on Caffeine?

The guidance below is the CPIC recommendation for prescribers, reproduced for reference. It is written for a clinician who knows the whole picture — never start, stop or change a medicine on the basis of this page.

PhenotypeCPIC-based guidance
Ultrarapid MetabolizerRapid caffeine metabolism. Higher caffeine tolerance, but high intake may still increase cardiovascular risk in some individuals.
Normal MetabolizerNormal caffeine metabolism. Moderate intake (up to 400mg/day) generally well tolerated.
Intermediate MetabolizerSlower caffeine metabolism. Consider limiting intake to 200mg/day. May experience prolonged stimulant effects.
Poor MetabolizerVery slow caffeine metabolism. Limit caffeine intake significantly (<100mg/day). Increased risk of insomnia, anxiety, and cardiovascular effects.

Evidence level B · PharmGKB / PMID:16522833. Phenotype definitions: CYP1A2 metaboliser phenotypes.

Which CYP1A2 alleles decide the phenotype?

The phenotype is read from the two CYP1A2 star alleles a person carries. The full allele table, with the defining variants and their population frequencies, is on the CYP1A2 gene page.

The inducibility variant *1F (rs762551) is on every major consumer chip. Because CYP1A2 activity depends heavily on smoking and diet, genotype alone predicts caffeine clearance less well than for other pharmacogenes.

Other drugs affected by CYP1A2

Check your CYP1A2 type before your next Caffeine conversation with a prescriber
Upload your raw DNA file and see your metaboliser status → · Ask G2: “Does my CYP1A2 genotype affect Caffeine?”

Genetic associations describe risk across populations, not a diagnosis for any one person. Most variants shift risk modestly and act alongside lifestyle, environment and other genes. Consumer DNA chips do not read every position and can be wrong at any single one. For general education only; talk to a clinician or genetic counsellor before acting on anything here, and never change a prescribed medicine without your prescriber.